Literature DB >> 11431006

Identification of delta- and mu-type opioid receptors on human and murine dendritic cells.

V P Makarenkova1, C Esche, N V Kost, G V Shurin, B S Rabin, A A Zozulya, M R Shurin.   

Abstract

The purpose of this study was to evaluate mu- and delta-opioid receptors (OR) on human and murine dendritic cells (DC). Expression of mu- and delta-OR mRNA on DC was demonstrated by RT-PCR. The immunocytochemical and Western blot analyses revealed the expression of OR protein in DC. Radioreceptor assay demonstrated the specific saturated temperature-dependent binding of [3H]-labeled opioid ligand on DC and B(max)=2.8+/-0.3 fmol/10(6) cells and K(D)=4.8+/-1.0 nM were calculated by a Scatchard analysis. Finally, OR ligands DADLE and DAGO dose-dependently modulated the capacity of DC to induce T cell proliferation in an MLR assay. Importantly, expression of functional OR on DC was significantly increased upon TNF-alpha-induced DC maturation. Thus, these data suggest a new mechanism of opioid-dependent neuroendocrine immunomodulation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11431006     DOI: 10.1016/s0165-5728(01)00313-7

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  12 in total

1.  Mu opioid receptor expression is increased in inflammatory bowel diseases: implications for homeostatic intestinal inflammation.

Authors:  D Philippe; D Chakass; X Thuru; P Zerbib; A Tsicopoulos; K Geboes; P Bulois; M Breisse; H Vorng; J Gay; J-F Colombel; P Desreumaux; M Chamaillard
Journal:  Gut       Date:  2005-11-18       Impact factor: 23.059

2.  Effect of chronic morphine administration on circulating dendritic cells in SIV-infected rhesus macaques.

Authors:  William D Cornwell; Wendeline Wagner; Mark G Lewis; Xiaoxuan Fan; Jay Rappaport; Thomas J Rogers
Journal:  J Neuroimmunol       Date:  2016-04-16       Impact factor: 3.478

3.  Morphine reciprocally regulates IL-10 and IL-12 production by monocyte-derived human dendritic cells and enhances T cell activation.

Authors:  Davorka Messmer; Ikusuke Hatsukari; Naoko Hitosugi; Ingo G H Schmidt-Wolf; Pravin C Singhal
Journal:  Mol Med       Date:  2006 Nov-Dec       Impact factor: 6.354

Review 4.  Role of the mu-opioid receptor in opioid modulation of immune function.

Authors:  Jana Ninković; Sabita Roy
Journal:  Amino Acids       Date:  2011-12-15       Impact factor: 3.520

Review 5.  Opioid Use, Gut Dysbiosis, Inflammation, and the Nervous System.

Authors:  Richa Jalodia; Yaa Fosuah Abu; Mark Ryan Oppenheimer; Bridget Herlihy; Jingjing Meng; Irina Chupikova; Junyi Tao; Nillu Ghosh; Rajib Kumar Dutta; Udhghatri Kolli; Yan Yan; Eridania Valdes; Madhulika Sharma; Umakant Sharma; Shamsudheen Moidunny; Sabita Roy
Journal:  J Neuroimmune Pharmacol       Date:  2022-01-07       Impact factor: 4.147

6.  Inducible expression of functional mu opioid receptors in murine dendritic cells.

Authors:  Zheng-Hong Li; Niansheng Chu; Li-Dong Shan; Shan Gong; Qi-Zhang Yin; Xing-Hong Jiang
Journal:  J Neuroimmune Pharmacol       Date:  2009-02-03       Impact factor: 4.147

7.  Anti-inflammatory properties of the mu opioid receptor support its use in the treatment of colon inflammation.

Authors:  David Philippe; Laurent Dubuquoy; Hervé Groux; Valérie Brun; Myriam Tran Van Chuoï-Mariot; Claire Gaveriaux-Ruff; Jean-Frédéric Colombel; Brigitte L Kieffer; Pierre Desreumaux
Journal:  J Clin Invest       Date:  2003-05       Impact factor: 14.808

8.  Comparison of stimulating effect on subpopulations of lymphocytes in human peripheral blood by methionine enkephalin with IL-2 and IFN-γ.

Authors:  Hui Hua; Changlong Lu; Weiwei Li; Jingjuan Meng; Danan Wang; Nicolas P Plotnikoff; Enhua Wang; Fengping Shan
Journal:  Hum Vaccin Immunother       Date:  2012-08-01       Impact factor: 3.452

9.  Opioids and clonidine modulate cytokine production and opioid receptor expression in neonatal immune cells.

Authors:  R Chavez-Valdez; L Kovell; R Ahlawat; G L McLemore; M Wills-Karp; E B Gauda
Journal:  J Perinatol       Date:  2012-10-04       Impact factor: 2.521

10.  Clinical evaluation of the efficacy of methylnaltrexone in resolving constipation induced by different opioid subtypes combined with laboratory analysis of immunomodulatory and antiangiogenic effects of methylnaltrexone.

Authors:  Elisabeth Cw Neefjes; Maurice Jdl van der Vorst; Manon Sa Boddaert; Wouter Wa Zuurmond; Hans J van der Vliet; Aart Beeker; Hendrik P van den Berg; Cornelis J van Groeningen; Suzan Vrijaldenhoven; Henk Mw Verheul
Journal:  BMC Palliat Care       Date:  2014-08-20       Impact factor: 3.234

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.